Released Apr 1, 2013, during market hours
10-K filed Apr 1, 2013, 91 days after period end · 0001437749-13-003783
Q4 2012 · 10-K
Revenue$1.94M$1.94M +256.2% vs Q4 2011+374.0% vs Q3 2012
Net Income-$249.92K-$249.92K N/M vs Q4 2011N/M vs Q3 2012
EPS Diluted$0.00$0.00 no prior Q4 2011 on fileno prior Q3 2012 on file
Gross Profit$1,619,925+358.5%
Operating Income-$237,666N/M
Operating Cash Flowderived$1,424N/M
Margins · derived
Gross margin83.4%+18.6 pt vs Q4 2011
Operating margin-12.2%+165.7 pt vs Q4 2011
Net margin-12.9%+171.1 pt vs Q4 2011
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2012 | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $1.94M | $545.45K | — |
| Net Income | -$249.92K | -$1.00M | — |
| EPS Diluted | $0.00 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Key International Inc · CIK 1019034 · Engraved from SEC EDGAR